A detailed history of Engineers Gate Manager LP transactions in Axogen, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 129,433 shares of AXGN stock, worth $1.81 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
129,433
Previous 160,819 19.52%
Holding current value
$1.81 Million
Previous $1.3 Million 27.76%
% of portfolio
0.02%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.67 - $8.06 $177,958 - $252,971
-31,386 Reduced 19.52%
129,433 $937,000
Q1 2024

May 15, 2024

BUY
$6.63 - $10.69 $91,460 - $147,468
13,795 Added 9.38%
160,819 $1.3 Million
Q4 2023

Feb 14, 2024

BUY
$3.61 - $7.76 $449,351 - $965,918
124,474 Added 551.99%
147,024 $1 Million
Q3 2023

Nov 14, 2023

BUY
$4.68 - $9.26 $27,822 - $55,050
5,945 Added 35.8%
22,550 $112,000
Q2 2023

Aug 14, 2023

BUY
$8.5 - $10.38 $27,990 - $34,181
3,293 Added 24.74%
16,605 $151,000
Q1 2023

May 15, 2023

BUY
$7.53 - $10.95 $100,239 - $145,766
13,312 New
13,312 $125,000
Q2 2022

Aug 15, 2022

SELL
$6.99 - $10.0 $482,883 - $690,820
-69,082 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$7.26 - $10.7 $72,796 - $107,288
-10,027 Reduced 12.67%
69,082 $549,000
Q4 2021

Feb 14, 2022

BUY
$8.8 - $16.0 $388,194 - $705,808
44,113 Added 126.05%
79,109 $741,000
Q3 2021

Nov 15, 2021

BUY
$15.23 - $21.72 $323,256 - $461,007
21,225 Added 154.13%
34,996 $553,000
Q2 2021

Aug 16, 2021

BUY
$17.8 - $23.5 $245,123 - $323,618
13,771 New
13,771 $298,000
Q1 2021

May 17, 2021

SELL
$17.18 - $22.6 $271,048 - $356,560
-15,777 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$11.5 - $17.96 $4,945 - $7,722
-430 Reduced 2.65%
15,777 $282,000
Q3 2020

Nov 16, 2020

BUY
$10.62 - $13.12 $172,118 - $212,635
16,207 New
16,207 $188,000
Q1 2020

May 15, 2020

SELL
$8.38 - $17.34 $103,518 - $214,201
-12,353 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$11.18 - $18.6 $161,875 - $269,309
-14,479 Reduced 53.96%
12,353 $221,000
Q3 2019

Nov 14, 2019

SELL
$12.09 - $20.46 $229,480 - $388,351
-18,981 Reduced 41.43%
26,832 $335,000
Q2 2019

Aug 14, 2019

BUY
$18.5 - $25.47 $847,540 - $1.17 Million
45,813 New
45,813 $907,000
Q3 2018

Nov 01, 2018

SELL
$34.05 - $55.9 $1.19 Million - $1.96 Million
-34,999 Closed
0 $0
Q2 2018

Aug 03, 2018

BUY
$36.15 - $52.5 $1.27 Million - $1.84 Million
34,999 New
34,999 $1.76 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $593M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.